DCF — OAKBEND MEDICAL CENTER
Enterprise Value: $-271.3M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-271.3M
Enterprise Value
$-85.0M
PV of Cash Flows
$-186.3M
PV of Terminal Value
$-300.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $144.2M | $-17.4M | -12.0% | $-23.5M | $-21.3M |
| Year 2 | $148.5M | $-16.4M | -11.0% | $-22.7M | $-18.8M |
| Year 3 | $153.0M | $-15.4M | -10.0% | $-21.8M | $-16.4M |
| Year 4 | $157.6M | $-15.0M | -10.0% | $-21.7M | $-14.8M |
| Year 5 | $162.3M | $-15.1M | -9.0% | $-22.0M | $-13.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-271.3M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$140.0M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.12544503534695234
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5